LLY
Eli Lilly andANYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
LLY vs peer average
84/100
LLY vs. peer average (A vs. C)
Grade spread
B 2 · C 4 · D 1 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Large-cap biotech operating peer with substantial cash generation and obesity-pipeline exposure, but less direct commercial GLP-1 momentum than Lilly.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
LLY
Eli Lilly and
AMGN
Amgen
Grade
A
D
Momentum
42
72
Value
60
63
Sentiment
82
42
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs AMGN
LLY / AMGN
Grade Position
Above peers
LLY vs. peer average (A vs. C)
84/100
Momentum
42
AMGNValue
60
AMGNSentiment
82
LLYRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs LLY
AMGN is the first peer returned for this comparison set.